Company: INTS
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001567264-25-000050
Chunk: 42

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 42
---
     |                 |        |
| Chair                                         |     | $               | 10,000 |
| Members                                       |     | $               |  5,000 |

Compensation Committee Interlocks and Insider Participation

The Compensation Committee of the Board of Directors is currently composed of the following three non-employee directors: Dr. Emer Leahy, Dr. Mark Goldberg, and Mr. Daniel Donovan. No member of the Compensation Committee is or was formerly an officer or employee of the Company during the last fiscal year. In addition, no executive officer of the Company serves on the compensation committee or board of directors of a company for which any of the Company’s directors serve as an executive officer.

<div align='center'>26</div>

### EQUITY COMPENSATION PLAN INFORMATION
The following table provides certain aggregate information with respect to all of our equity compensation plans in effect as of December 31, 2024.

| Plan Category                                          |     | Number of Shares ofCommon Stock to beIssued upon Exercise ofOutstanding Options(1) 
 (a)                                                                                |     |           |     | Weighted-Average    
 Exercise Price of   
 Outstanding Options 
 (b)                 |      |   |     | Number ofSecuritiesRemainingAvailable forFuture IssuanceUnder EquityCompensationPlans (excludingsecuritiesreflected incolumn (a))(2) 
 (c)                                                                                                                                  |     |           |
|:-------------------------------------------------------|:----|:-----------------------------------------------------------------------------------|:----|----------:|:----|:--------------------|-----:|:--|:----|:-------------------------------------------------------------------------------------------------------------------------------------|:----|----------:|
| Equity compensation plans approved by stockholders     |     |                                                                                    |     | 2,587,129 |     | $                   | 6.14 |   |     |                                                                                                                                      |     | 1,881,649 |
| Equity compensation plans not approved by stockholders |     |                                                                                    |     |         – |     |                     |      | – |     |                                                                                                                                      |     |         – |
| Total                                                  |     |                                                                                    |     | 2,587,129 |     | $                   | 6.14 |   |     |                                                                                                                                      |     | 1,881,649 |

(1) The amounts shown in this column include securities under both the 2013 Plan and 2021 Plan.

(2) Consists entirely of securities under the 2021 Plan. The 2021 Plan contains an “evergreen” provision,